Lv2
130 积分 2022-08-17 加入
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges
9小时前
已完结
A comprehensive review of the truck appointment scheduling models and directions for future research
24天前
已完结
VQ-DoseNet: A vector quantized model for stochastic radiotherapy dose prediction
1个月前
已完结
Induction chemotherapy and molecular MRD influence outcomes in KMT2A -rearranged AML
4个月前
已关闭
A Relapsing Meningeal Acute Myeloid Leukaemia FLT3-ITD+ Responding to Gilteritinib
5个月前
已完结
Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation
9个月前
已完结
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia
11个月前
已完结
Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough?
1年前
已完结
How I use Maintenance Therapy in Acute Myeloid Leukemia
1年前
已完结
TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?
1年前
已完结
皖公网安备34019202002308
